Jesy Nelson's SMA Campaign Wins! National Screening for All Newborns
Jesy Nelson's SMA Campaign Wins! National Screening for All Newborns
Huge news for families! Jesy Nelson's tireless campaign for Spinal Muscular Atrophy (SMA) screening leads to national rollout in England. Early diagnosis offers hope for future generations. #SMAScreening
In a monumental victory for families across England, a full national rollout of the newborn screening programme for Spinal Muscular Atrophy (SMA) has been confirmed, largely thanks to the tireless campaign led by former Little Mix star, Jesy Nelson. This significant development, announced by the Department of Health, means hundreds of thousands of infants will now be screened for the rare genetic condition via a simple heel prick blood test shortly after birth.
Jesy Nelson’s passionate advocacy was ignited by a deeply personal experience: the diagnosis of her twins, Ocean Jade and Story Monroe Nelson, with SMA. This condition causes muscles to progressively weaken and waste away, making early detection crucial for better treatment outcomes.
The singer hailed the news as "a victory for every family affected" and a "day of hope." She expressed immense pride in having supported a cause that will grant future families access to early diagnosis and the opportunity for the best possible outcomes. Nelson acknowledged that while this cannot change the future for her own children, it marks "the beginning of a brighter future for future SMA families."
The rollout will commence from the end of this year, with implementation continuing throughout 2027 until every newborn screening laboratory across the UK is offering the test. This comprehensive approach addresses previous concerns raised by Nelson, who last month voiced her "heartbreak" over an announcement that would only cover 72% of England, creating a "postcode lottery." She passionately argued that "Every baby deserves the same chance, every baby’s life matters." The new plan ensures that all parts of England will now benefit from this vital screening, offering universal access and equitable care.
